N-(Adamantan-2-yl)-4-bromobenzamide

ID: ALA4865942

Chembl Id: CHEMBL4865942

PubChem CID: 867354

Max Phase: Preclinical

Molecular Formula: C17H20BrNO

Molecular Weight: 334.26

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NC1C2CC3CC(C2)CC1C3)c1ccc(Br)cc1

Standard InChI:  InChI=1S/C17H20BrNO/c18-15-3-1-12(2-4-15)17(20)19-16-13-6-10-5-11(8-13)9-14(16)7-10/h1-4,10-11,13-14,16H,5-9H2,(H,19,20)

Standard InChI Key:  DYLWMFBGCSKYFJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPG057 Envelope phospholipase F13 (p37) (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 334.26Molecular Weight (Monoisotopic): 333.0728AlogP: 4.00#Rotatable Bonds: 2
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.99CX LogD: 3.99
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.87Np Likeness Score: -0.76

References

1. Shiryaev VA, Skomorohov MY, Leonova MV, Bormotov NI, Serova OA, Shishkina LN, Agafonov AP, Maksyutov RA, Klimochkin YN..  (2021)  Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.,  221  [PMID:33965861] [10.1016/j.ejmech.2021.113485]

Source